Cellebrite DI Ltd.
CLBTTechnologyNASDAQSoftware - Infrastructure
Scan Results
Daily timeframePart of the technology sector, Cellebrite DI Ltd. (CLBT) is listed under Software - Infrastructure. At a $2.88B market cap, Cellebrite DI Ltd. ranks as a mid-cap company within technology. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency.
Market Cap
$2.88B
Beta
1.15
P/E (TTM)
49.78
P/E (Fwd)
17.53
EPS (TTM)
$0.23
EPS (Fwd)
$0.65
ROE
12.4%
ROA
3.9%
Cash
$442.5M
Total Debt
$23.2M
Free CF
$124.9M
52W Change
-33.7%
Annual Financials
Cash vs Debt
Where CLBT stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, CLBT finished 15.49% below its 150-day moving average ($13.75) and 21.27% below its 200-day moving average ($14.76). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CLBT overbought or oversold?
At the September 3, 2026 close, CLBT's RSI(14) was 59.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Cellebrite DI Ltd. holds $442.5M in cash against $23.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $124.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 12.4%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $270.7M (2022) to $475.7M (2025), reflecting a 76% increase over the period.
With cash comfortably exceeding debt, CLBT has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CLBT.